Form 4: Aurinia Pharmaceuticals EVP, General Counsel Sells Shares to Cover Tax Obligations

Stephen P. Robertson, EVP and General Counsel of Aurinia Pharmaceuticals, sold 57,745 shares of common stock on March 6, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Stephen P. Robertson, the EVP and General Counsel of Aurinia Pharmaceuticals Inc., sold 57,745 shares of common stock on March 6, 2024.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units granted on March 2, 2022, and March 2, 2023.
• The shares were sold at a weighted average price of $5.6, with individual transactions ranging from $5.475 to $5.755.
• Following the transaction, Robertson directly owns 443,824 shares of Aurinia Pharmaceuticals Inc.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover taxes). It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact given the reason for the sale.

Key Dates